Evaluating stress management for caregivers of cancer patients
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers
This study tests different stress management programs to see if they can help caregivers of cancer patients feel less stressed while supporting their loved ones during treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 540 (estimated) |
| Ages | 21 Years and up |
| Sex | All |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute Academic / other |
| Locations | 1 site (Tampa, Florida) |
| Trial ID | NCT05078229 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of various stress management interventions on the stress levels of caregivers for patients undergoing allogeneic hematopoietic cell transplantation (HCT). It focuses on caregivers who are primary support for patients at Moffitt Cancer Center and evaluates how these interventions can alleviate caregiver burden. Participants will engage in different programs designed to promote healthy living and stress reduction. The study will measure the impact of these interventions on both caregivers and patients throughout the treatment process.
Who should consider this trial
Good fit: Ideal candidates include caregivers of patients planning to receive allogeneic HCT at Moffitt Cancer Center who can commit to being the primary caregiver throughout treatment.
Not a fit: Patients who are not receiving their transplant at Moffitt Cancer Center or those who cannot remain primary caregivers will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce stress and improve the well-being of caregivers, leading to better support for cancer patients.
How similar studies have performed: Other studies have shown positive outcomes with stress management interventions for caregivers in similar healthcare settings, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Caregiver Inclusion Criteria: * Caring for a patient planning to receive an allogeneic HCT at Moffitt * Intending to remain primary caregiver throughout patient treatment (i.e., will be the caregiver the majority of the time) * Able to provide informed consent * Able to read and write in English * Owns a smartphone and is willing to download the study app * Patient Inclusion Criteria: * Receiving an allogeneic HCT at the cancer center * Able to provide informed consent * Able to read and write in English Exclusion Criteria: * Under 21 years of age * Unable to provide informed consent * Unable to read and write in English * Caregiver is unable to remain primary caregiver throughout patient treatment * Patient does not receive transplant at Moffitt Cancer Center
Where this trial is running
Tampa, Florida
- Moffitt Cancer Center — Tampa, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Christine Vinci, PhD — Moffitt Cancer Center
- Study coordinator: Sierra Washington
- Email: Sierra.Washington@moffitt.org
- Phone: 1 813-745-5178
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.